Daily Market Reports | Mar 17 2026
This story features ARISTOCRAT LEISURE LIMITED, and other companies.
For more info SHARE ANALYSIS: ALL
The company is included in ASX20, ASX50, ASX100, ASX200, ASX300 and ALL-ORDS
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ALL CKF DUG FPR GHM HRZ ILA LTR LYC MAQ MLX MM8 MTM PFP PV1 RIC TLX TOR TTM VBC WGX
ALL ARISTOCRAT LEISURE LIMITED
Gaming – Overnight Price: $45.87
Jarden rates ((ALL)) as Buy (1) –
Jarden notes Aristocrat Leisure has extended its market leadership in Australia and expects the presentation at the Australian Hotels and Gaming Expo at the end of this month to highlight its performance and ship-share gains.
The Dragon Link franchise continues to have several titles amongst the highest performing games, nine years post its initial launch.
The broker increases FY26 EPS estimates by 3% to reflect increased Australian units and the full benefit of the litigation settlement with Light & Wonder ((LNW)). Buy rating retained along with a $68 target.
This report was published on March 12, 2026.
Target price is $68.00 Current Price is $45.87 Difference: $22.13
If ALL meets the Jarden target it will return approximately 48% (excluding dividends, fees and charges).
Current consensus price target is $67.31, suggesting upside of 46.8%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 105.00 cents and EPS of 260.30 cents.
At the last closing share price the estimated dividend yield is 2.29%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.62.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 260.4, implying annual growth of 13.6%.
Current consensus DPS estimate is 95.4, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 17.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 115.00 cents and EPS of 286.50 cents.
At the last closing share price the estimated dividend yield is 2.51%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.01.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 292.1, implying annual growth of 12.2%.
Current consensus DPS estimate is 106.0, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 15.7.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CKF COLLINS FOODS LIMITED
Food, Beverages & Tobacco – Overnight Price: $9.81
Jarden rates ((CKF)) as Upgrade to Overweight from Neutral (2) –
Collins Foods has reported stronger second-half trading with same-store sales growth accelerating versus the first half, Jarden highlights. Guidance for mid-high teens profit growth was reaffirmed.
The broker notes the acquisition of eight Bavarian restaurants at around a 6x earnings multiple, expected to be immediately earnings accretive.
The transaction is expected to open a new German market and lift the company’s expansion target to 45-90 stores over four years.
FY26-FY28 profit forecasts rise by 2-5% after incorporating the acquisition and stronger trading momentum.
Jarden upgrades to Overweight from Neutral and raises its target price to $12.10 from $11.40.
This report was published on March 11, 2026.
Target price is $12.10 Current Price is $9.81 Difference: $2.29
If CKF meets the Jarden target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $12.41, suggesting upside of 26.5%(ex-dividends)
The company’s fiscal year ends in April.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 52.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.65.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 51.6, implying annual growth of 588.0%.
Current consensus DPS estimate is 29.2, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 19.0.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of 63.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.52.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 61.3, implying annual growth of 18.8%.
Current consensus DPS estimate is 35.5, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 16.0.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
DUG DUG TECHNOLOGY LIMITED
Cloud services – Overnight Price: $2.02
Shaw and Partners rates ((DUG)) as Buy (1) –
DUG Technology has invested almost -$60m in high-performance computing infrastructure over the last several years and, as revenue now scales up and the required expenditure moderates, Shaw and Partners expects this to drive operating leverage and a re-rating of the stock.
Commentary highlights the business is favourably exposed to a rising oil price and has limited direct revenue exposure to the Middle East.
Having materially underperformed its O&G service peers, the broker reiterates a Buy, High Risk rating, transferring coverage to Jules Cooper.
Target is $3.00, down from $3.20.
This report was published on March 17, 2026.
Target price is $3.00 Current Price is $2.02 Difference: $0.98
If DUG meets the Shaw and Partners target it will return approximately 49% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 5.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 40.40.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 9.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.96.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
FPR FLEETPARTNERS GROUP LIMITED
Vehicle Leasing & Salary Packaging – Overnight Price: $2.62
Canaccord Genuity rates ((FPR)) as Buy (1) –
FleetPartners Group will undertake a buyback for up to $20m, a little less than 4% at current prices, which Canaccord Genuity considers significant, given the company had changed its capital management plans from primarily buybacks to primarily dividends.
The broker believes the decision is a sign of conviction in the current performance and the trading multiple of the stock. It should also provide a “smoother” transition from one strategy to the other.
Canaccord Genuity considers the stock attractive at current levels. Buy rating and $3.60 target price are retained.
This report was published on March 10, 2026.
Target price is $3.60 Current Price is $2.62 Difference: $0.98
If FPR meets the Canaccord Genuity target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $3.45, suggesting upside of 31.8%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 38.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.74.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 34.7, implying annual growth of 3.4%.
Current consensus DPS estimate is 24.8, implying a prospective dividend yield of 9.5%.
Current consensus EPS estimate suggests the PER is 7.6.
Forecast for FY27:
Current consensus EPS estimate is 33.7, implying annual growth of -2.9%.
Current consensus DPS estimate is 23.2, implying a prospective dividend yield of 8.9%.
Current consensus EPS estimate suggests the PER is 7.8.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GHM GOLDEN HORSE MINERALS LIMITED
Gold & Silver – Overnight Price: $0.56
Shaw and Partners rates ((GHM)) as Buy (1) –
Golden Horse Minerals will start metallurgical studies in the second quarter at Hopes Hill. Shaw and Partners notes, supported by a large drilling campaign and extensive landholding, the business is strategically positioned to benefit from strong gold prices and a looming maiden resource estimate.
The company has confirmed recent analysis of core samples from Hopes Hill have indicated gold is free milling, existing a separate grains within fractured quartz rather than being trapped inside other minerals. This suggests it can be easily extracted.
Buy, High Risk rating and $1.50 target are maintained.
This report was published on March 17, 2026.
Target price is $1.50 Current Price is $0.56 Difference: $0.945
If GHM meets the Shaw and Partners target it will return approximately 170% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 3.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 15.86.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 2.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 26.43.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
HRZ HORIZON MINERALS LIMITED
Gold & Silver – Overnight Price: $0.92
Research as a Service (RaaS) rates ((HRZ)) as No Rating (-1) –
Horizon Minerals has updated on the Phillips Find joint venture, having received a cash distribution of $10m. A final distribution is expected in April from the processing of a low-grade stockpile, another 30,000t.
The outcome from the JV has beaten Research as a Service (RaaS) estimates in terms of both output and higher realised gold prices. The valuation, as a result of cash distribution, implied expenditure and marking to market investment holdings, edges down to $2.978 from $2.988.
Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 13, 2026.
Target price is $2.98 Current Price is $0.92 Difference: $2.058
If HRZ meets the Research as a Service (RaaS) target it will return approximately 224% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.26 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 73.02.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of 7.76 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.86.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ILA ISLAND PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.42
Research as a Service (RaaS) rates ((ILA)) as No Rating (-1) –
Island Pharmaceuticals in collaboration with Burnet Institute will test its two antiviral compounds, ISLA-101 and Galidesivir, against additional viruses; measles, chikungunya and Ross River virus.
Research as a Service (RaaS) notes the indications have been chosen as they aligned with national stockpile, bio defence and public health frameworks and interesting as previously ISLA-101 was focused on dengue and Galidesivir on Marburg.
Valuation remains at $1.24.
Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 13, 2026.
Target price is $1.24 Current Price is $0.42 Difference: $0.82
If ILA meets the Research as a Service (RaaS) target it will return approximately 195% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.77 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 23.73.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 4.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 8.94.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
LTR LIONTOWN LIMITED
New Battery Elements – Overnight Price: $1.58
Jarden rates ((LTR)) as Underweight (4) –
The first half results from Liontown beat Jarden’s estimates, mainly from timing differences. FY26 guidance is unchanged with spodumene concentrate production of 365-450,000t and F.O.B. costs of $855-1045/t, with the overall outcome still heavily dependent on a strong June quarter.
The broker continues to hold the stock in high regard for its delivery and early operating performance at Kathleen Valley yet maintains “valuation discipline” so an Underweight rating is upheld until a more attractive entry point is achieved. Target is steady at $0.62.
This report was published on March 12, 2026.
Target price is $0.62 Current Price is $1.58 Difference: minus $0.965 (current price is over target).
If LTR meets the Jarden target it will return approximately minus 61% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $1.94, suggesting upside of 21.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of minus 1.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 132.08.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 1.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 83.7.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of minus 4.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 37.74.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 14.2, implying annual growth of 647.4%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 11.2.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
LYC LYNAS RARE EARTHS LIMITED
Rare Earth Minerals – Overnight Price: $20.99
Canaccord Genuity rates ((LYC)) as Buy (1) –
Lynas Rare Earths and Japan Australia Rare Earths have revised terms for the existing offtake arrangement.
The latter has provided a firm commitment to purchase 5000tpa for supply to Japanese industry with an agreed market-linked floor of US$110/kg and a 30% profit share at prices over US$150/kg.
Canaccord Genuity considers the revised supply arrangement a major positive for Lynas while the revised offtake is providing insulation from any influence China will have on rare earth pricing.
Modelling is updated and EBITDA estimates lifted by around 50%. Target rises to $22.00 from $18.60 and a Buy rating is unchanged.
This report was published on March 11, 2026.
Target price is $22.00 Current Price is $20.99 Difference: $1.01
If LYC meets the Canaccord Genuity target it will return approximately 5% (excluding dividends, fees and charges).
Current consensus price target is $17.23, suggesting downside of -17.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents.
How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 35.4, implying annual growth of 4064.7%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 59.3.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents.
How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 69.6, implying annual growth of 96.6%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 30.2.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MAQ MACQUARIE TECHNOLOGY GROUP LIMITED
Cloud services – Overnight Price: $65.00
Canaccord Genuity rates ((MAQ)) as Buy (1) –
Canaccord Genuity considers a $200m investment from Australia’s National Reconstruction Fund a strong endorsement of the Macquarie Technology business and the quality of its cloud services & government offering in particular.
The instrument, with the company issuing up to $200m in hybrid securities to the NRF, will be on the balance sheet as non-dilutive equity and provide significant flexibility for future funding options.
Also a positive, the broker contends, is that the funds will be deployed to grow areas of the business outside the data centre segment. Buy rating and $95 target unchanged.
This report was published on March 11, 2026.
Target price is $95.00 Current Price is $65.00 Difference: $30
If MAQ meets the Canaccord Genuity target it will return approximately 46% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 105.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 61.90.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 42.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 154.76.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MLX METALS X LIMITED
Tin – Overnight Price: $1.23
Canaccord Genuity rates ((MLX)) as Buy (1) –
Canaccord Genuity found the full year result from Metals X largely in line with expectations. The company has entered the year with a cash position of $294m and no debt. The focus remains on growth and therefore no dividends were declared.
The broker increases its tin price forecast for 2026-27 to US$50,000/t with the target raised to $1.50 from $1.35.
Continued pressure on the market is anticipated and the stock is considered a defensive play while leveraged to the strength in tin pricing. Buy rating unchanged.
This report was published on March 10, 2026.
Target price is $1.50 Current Price is $1.23 Difference: $0.275
If MLX meets the Canaccord Genuity target it will return approximately 22% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 15.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.17.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 15.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.17.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MM8 MEDALLION METAL LIMITED
Gold & Silver – Overnight Price: $0.45
Canaccord Genuity rates ((MM8)) as Speculative Buy (1) –
Medallion Metals has validated initial historical results from the Lounge Lizard deposit, within the recently acquired Forrestania gold project. Canaccord Genuity points out Lounge Lizard represents one of several gold opportunities at the project with additional holes currently being validated and assessed for release.
Mineralisation is defined over a 1 kilometre strike remaining open at depth and along strike and the broker points out historical drilling demonstrates robust near-surface and deeper high-grade widths including 23m at 5.85g/t from 13m , 20m at 4.44g/t from 15m and 6m at 9.20g/t from 112m.
Speculative Buy rating and $0.95 target unchanged.
This report was published on March 11, 2026.
Target price is $0.95 Current Price is $0.45 Difference: $0.505
If MM8 meets the Canaccord Genuity target it will return approximately 113% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 44.50.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MTM METALLIUM LIMITED
Industrial Metals – Overnight Price: $0.64
Canaccord Genuity rates ((MTM)) as Speculative Buy (1) –
Metallium has successfully wet commissioned a Flash Joule Heating line with the first chlorine flash operating in line with design expectations, which Canaccord Genuity considers a major de-risking of the FJH technology.
The company is now progressing with the demonstration of three simultaneous FJH reactors ahead of the stage I commissioning of 24 reactors.
The broker envisages delivery of commercial-scale production and confirmation of throughput, recoveries and feed grades will be a major de-risking of the investment case and potential catalyst.
The Speculative Buy rating and $1.60 target are unchanged.
This report was published on March 11, 2026.
Target price is $1.60 Current Price is $0.64 Difference: $0.96
If MTM meets the Canaccord Genuity target it will return approximately 150% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 1.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 64.00.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 12.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.33.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PFP PROPEL FUNERAL PARTNERS LIMITED
Consumer Products & Services – Overnight Price: $4.31
Jarden rates ((PFP)) as Initiation of coverage with Overweight (2) –
Jarden initiates coverage of Propel Funeral Partners with a $5 target and Overweight rating, noting the defensive characteristics of the stock. The broker observes the company has had a “tough” 12 months, driving share price underperformance versus the S&P/ASX300.
While the forward PE of 26x is not “cheap”, Jarden envisages attractive risk-adjusted returns, expecting industry volumes to return to 2% growth per annum and noting M&As are particularly lumpy.
The broker suspects the business could potentially deploy around $40m per annum for the next 10 years in terms of M&As, driving 11% compound growth to EPS and still be at a lower market share than InvoCare.
This report was published on March 12, 2026.
Target price is $5.00 Current Price is $4.31 Difference: $0.69
If PFP meets the Jarden target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $5.88, suggesting upside of 36.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 16.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.96.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 16.9, implying annual growth of 14.3%.
Current consensus DPS estimate is 14.0, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 25.5.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of 17.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.63.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.8, implying annual growth of 11.2%.
Current consensus DPS estimate is 15.4, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 22.9.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PV1 PROVARIS ENERGY LIMITED
Energy – Overnight Price: $0.01
Research as a Service (RaaS) rates ((PV1)) as No Rating (-1) –
Provaris Energy presents a unique investment opportunity in the global shift to alternative energy and carbon reduction, Research as a Service (RaaS) suggests.
A recently completed capital raising underpins critical work in the commercial pathway through the fabrication, testing and the class approval of its proprietary hydrogen tank prototype.The broker also notes the commercialisation of the carbon dioxide development model is become materially more advanced.
An immediate re-rating outcome is predicated on the delivery of class approval on the hydrogen tank to underpin FID for an initial development. The broker’s valuation range is $0.08-0.16 with the midpoint at $0.13 as the base case.
Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 13, 2026.
Target price is $0.13 Current Price is $0.01 Difference: $0.12
If PV1 meets the Research as a Service (RaaS) target it will return approximately 1200% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 EPS of minus 0.29 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 3.45.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 EPS of minus 0.37 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 2.70.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
RIC RIDLEY CORPORATION LIMITED
Agriculture – Overnight Price: $2.72
Canaccord Genuity rates ((RIC)) as Buy (1) –
At its investor briefing, Ridley Corp announced a new three-year strategic plan which validated Canaccord Genuity’s expectations for sustained earnings growth over the medium term.
There are a range of existing initiatives and new and tangible updates that present upside risk to forecast. In particular, the broker is encouraged earnings in FY26 will not be materially affected by supply constraints in the Middle East.
The company expects FY26 group earnings to be driven by the nine months contribution from the fertiliser segment including a second-half seasonal peak in demand, as well as increased market share and volume-related operating efficiency in the bulk stockfeed segment.
Buy rating and $3.52 target unchanged.
This report was published on March 11, 2026.
Target price is $3.52 Current Price is $2.72 Difference: $0.8
If RIC meets the Canaccord Genuity target it will return approximately 29% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 10.30 cents and EPS of 15.00 cents.
At the last closing share price the estimated dividend yield is 3.79%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.13.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 13.50 cents and EPS of 20.00 cents.
At the last closing share price the estimated dividend yield is 4.96%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.60.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TLX TELIX PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $10.98
Canaccord Genuity rates ((TLX)) as Buy (1) –
Telix Pharmaceuticals has communicated positive results from a lead-in cohort study, a component of its Prost ACT GLOBAL phase 3, assessing the feasibility, safety and dosimetric features of combining TLX591 with three proposed standards of care in mCRPC treatment.
The data points show all three combinations exhibited acceptable safety signals. The company plans to share the data with the US FDA and other regulators.
Canaccord Genuity has a Buy rating and $28.50 target.
This report was published on March 10, 2026.
Target price is $28.50 Current Price is $10.98 Difference: $17.52
If TLX meets the Canaccord Genuity target it will return approximately 160% (excluding dividends, fees and charges).
Current consensus price target is $25.84, suggesting upside of 135.3%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is -10.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Current consensus EPS estimate is 18.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 58.7.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TOR TORQUE METALS LIMITED
Gold & Silver – Overnight Price: $0.46
Canaccord Genuity rates ((TOR)) as Speculative Buy (1) –
Torque Metals has appointed a Western Australian gold exploration and development team for the next phase of growth at the Paris gold project, south Kalgoorlie. The group previously led Spartan Resources, which merged with Ramelius Resources ((RMS)).
As part of the leadership transition, Craig Jones will assume the CEO role immediately and become managing director following shareholder approval.
A new technical team has begun reviewing historical exploration data with the intention of accelerating exploration and drilling in 2026.
Canaccord Genuity envisages potential for more than 1.6m ounces to be defined across the project over time and its Speculative Buy rating and $0.55 target are maintained.
This report was published on March 11, 2026.
Target price is $0.55 Current Price is $0.46 Difference: $0.09
If TOR meets the Canaccord Genuity target it will return approximately 20% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.01 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 4600.00.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 0.01 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 4600.00.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TTM TITAN MINERALS LIMITED
Gold & Silver – Overnight Price: $0.96
Canaccord Genuity rates ((TTM)) as Speculative Buy (1) –
Titan Minerals has intersected extensive porphyry-hosted gold/silver/copper in realisation at the Kaliman target in the Dynasty gold project in Ecuador.
Mineralisation remains open along strike and at depth which highlights the projects potential for a large bulk-mining operation, Canaccord Genuity asserts.
The porphyry-hosted mineralisation will be incorporated into the upcoming resource estimate, expected later this month. The inclusion should materially increase the project scale and support future development studies, commentary suggests.
Speculative Buy rating with a $1.95 target unchanged.
This report was published on March 11, 2026.
Target price is $1.95 Current Price is $0.96 Difference: $0.99
If TTM meets the Canaccord Genuity target it will return approximately 103% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
VBC VERBREC LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $0.22
Research as a Service (RaaS) rates ((VBC)) as No Rating (-1) –
Verbrec posted revenue growth of 18.5% and EBITDA growth of 135.3% in its first half. Research as a Service (RaaS) noted two significant events occurred, being the acquisition of Alliance Automation and divestment of Competency Training.
Importantly, the engineering business performed strongly. The broker believes the combined business with Alliance Automation will strengthen the engineering offering and as a result the opportunity and work in hand have both grown by more than 50%.
Valuation of $0.44 is unchanged.
Research as a Service (RaaS) research standard doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 11, 2026.
Target price is $0.44 Current Price is $0.22 Difference: $0.22
If VBC meets the Research as a Service (RaaS) target it will return approximately 100% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.50 cents and EPS of 1.20 cents.
At the last closing share price the estimated dividend yield is 2.27%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.33.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.60 cents and EPS of 1.90 cents.
At the last closing share price the estimated dividend yield is 2.73%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.58.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
WGX WESTGOLD RESOURCES LIMITED
Gold & Silver – Overnight Price: $5.95
Canaccord Genuity rates ((WGX)) as Buy (1) –
Westgold Resources has approved the expansion of the Higginsville processing plant to 2.6mtpa.
Expansion expenditure is estimated at -$145m, broadly in line with Canaccord Genuity’s expectations and compares with the company’s three-year guidance of -$130m.
The modest uplift in capital expenditure reflects DFS level engineering, cost escalation and a decision to “future proof” key front-end equipment for potential future expansion to 4mtpa, commentary suggests.
The broker adjusts its modelling, increasing the target to $8.75 from $8.50. Buy rating retained.
This report was published on March 10, 2026.
Target price is $8.75 Current Price is $5.95 Difference: $2.8
If WGX meets the Canaccord Genuity target it will return approximately 47% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 9.00 cents and EPS of 57.00 cents.
At the last closing share price the estimated dividend yield is 1.51%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.44.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 12.00 cents and EPS of 98.00 cents.
At the last closing share price the estimated dividend yield is 2.02%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.07.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: ALL - ARISTOCRAT LEISURE LIMITED
For more info SHARE ANALYSIS: CKF - COLLINS FOODS LIMITED
For more info SHARE ANALYSIS: DUG - DUG TECHNOLOGY LIMITED
For more info SHARE ANALYSIS: FPR - FLEETPARTNERS GROUP LIMITED
For more info SHARE ANALYSIS: GHM - GOLDEN HORSE MINERALS LIMITED
For more info SHARE ANALYSIS: ILA - ISLAND PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: LNW - LIGHT & WONDER INC
For more info SHARE ANALYSIS: LTR - LIONTOWN LIMITED
For more info SHARE ANALYSIS: LYC - LYNAS RARE EARTHS LIMITED
For more info SHARE ANALYSIS: MAQ - MACQUARIE TECHNOLOGY GROUP LIMITED
For more info SHARE ANALYSIS: MLX - METALS X LIMITED
For more info SHARE ANALYSIS: MM8 - MEDALLION METAL LIMITED
For more info SHARE ANALYSIS: MTM - METALLIUM LIMITED
For more info SHARE ANALYSIS: PFP - PROPEL FUNERAL PARTNERS LIMITED
For more info SHARE ANALYSIS: PV1 - PROVARIS ENERGY LIMITED
For more info SHARE ANALYSIS: RIC - RIDLEY CORPORATION LIMITED
For more info SHARE ANALYSIS: RMS - RAMELIUS RESOURCES LIMITED
For more info SHARE ANALYSIS: TLX - TELIX PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: TOR - TORQUE METALS LIMITED
For more info SHARE ANALYSIS: TTM - TITAN MINERALS LIMITED
For more info SHARE ANALYSIS: VBC - VERBREC LIMITED
For more info SHARE ANALYSIS: WGX - WESTGOLD RESOURCES LIMITED